| HIV testing: increasing uptake among people who may have undiagnosed HIV | NG60 | | |
| Tobacco: preventing uptake, promoting quitting and treating dependence | NG209 | | |
| Epilepsies in children, young people and adults | NG217 | | |
| Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years | NG247 | | |
| Urinary tract infection (recurrent): antimicrobial prescribing | NG112 | | |
| Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
| Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education | NG213 | | |
| Advocacy services for adults with health and social care needs | NG227 | | |
| Self-harm: assessment, management and preventing recurrence | NG225 | | |
| Cefiderocol for treating severe drug-resistant gram-negative bacterial infections | AMR2 | | |
| Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections | AMR1 | | |
| Social, emotional and mental wellbeing in primary and secondary education | NG223 | | |
| Reducing sexually transmitted infections | NG221 | | |
| Social work with adults experiencing complex needs | NG216 | | |
| Vaccine uptake in the general population | NG218 | | |
| Integrated health and social care for people experiencing homelessness | NG214 | | |
| Otitis media (acute): antimicrobial prescribing | NG91 | | |
| Mental wellbeing at work | NG212 | | |
| Looked-after children and young people | NG205 | | |
| Clostridioides difficile infection: antimicrobial prescribing | NG199 | | |
| Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
| Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing | NG190 | | |
| Safeguarding adults in care homes | NG189 | | |
| Human and animal bites: antimicrobial prescribing | NG184 | | |
| Behaviour change: digital and mobile health interventions | NG183 | | |
| Insect bites and stings: antimicrobial prescribing | NG182 | | |
| Impetigo: antimicrobial prescribing | NG153 | | |
| Antenatal and postnatal mental health: clinical management and service guidance | CG192 | | |
| Leg ulcer infection: antimicrobial prescribing | NG152 | | |
| Supporting adult carers | NG150 | | |
| Indoor air quality at home | NG149 | | |
| Workplace health: long-term sickness absence and capability to work | NG146 | | |
| End of life care for adults: service delivery | NG142 | | |
| Diabetic foot problems: prevention and management | NG19 | | |
| Cellulitis and erysipelas: antimicrobial prescribing | NG141 | | |
| Alcohol interventions in secondary and further education | NG135 | | |
| End of life care for infants, children and young people with life-limiting conditions: planning and management | NG61 | | |
| Motor neurone disease: assessment and management | NG42 | | |
| Cough (acute): antimicrobial prescribing | NG120 | | |
| Cerebral palsy in adults | NG119 | | |
| Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing | NG117 | | |
| Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing | NG114 | | |
| Urinary tract infection (catheter-associated): antimicrobial prescribing | NG113 | | |
| Urinary tract infection (lower): antimicrobial prescribing | NG109 | | |
| Prostatitis (acute): antimicrobial prescribing | NG110 | | |
| Pyelonephritis (acute): antimicrobial prescribing | NG111 | | |
| Decision-making and mental capacity | NG108 | | |
| Preventing suicide in community and custodial settings | NG105 | | |
| Flu vaccination: increasing uptake | NG103 | | |
| Community pharmacies: promoting health and wellbeing | NG102 | | |
| Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
| Care and support of people growing older with learning disabilities | NG96 | | |
| Learning disabilities and behaviour that challenges: service design and delivery | NG93 | | |
| Physical activity and the environment | NG90 | | |
| People's experience in adult social care services: improving the experience of care and support for people using adult social care services | NG86 | | |
| Sore throat (acute): antimicrobial prescribing | NG84 | | |
| Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
| Sinusitis (acute): antimicrobial prescribing | NG79 | | |
| Cystic fibrosis: diagnosis and management | NG78 | | |
| Child abuse and neglect | NG76 | | |
| Intermediate care including reablement | NG74 | | |
| Type 2 diabetes: prevention in people at high risk | PH38 | | |
| Vitamin D: supplement use in specific population groups | PH56 | | |
| Air pollution: outdoor air quality and health | NG70 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Sexually transmitted infections: condom distribution schemes | NG68 | | |
| Managing medicines for adults receiving social care in the community | NG67 | | |
| Patient group directions | MPG2 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Drug misuse prevention: targeted interventions | NG64 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
| Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
| Physical health of people in prison | NG57 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Harmful sexual behaviour among children and young people | NG55 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Transition between inpatient mental health settings and community or care home settings | NG53 | | |
| Oral health for adults in care homes | NG48 | | |
| Controlled drugs: safe use and management | NG46 | | |
| Workplace health: management practices | NG13 | | |
| Community engagement: improving health and wellbeing and reducing health inequalities | NG44 | | |
| Transition from children's to adults' services for young people using health or social care services | NG43 | | |
| Sunlight exposure: risks and benefits | NG34 | | |
| Skin cancer prevention | PH32 | | |
| Older people: independence and mental wellbeing | NG32 | | |
| Care of dying adults in the last days of life | NG31 | | |
| Oral health promotion: general dental practice | NG30 | | |
| Transition between inpatient hospital settings and community or care home settings for adults with social care needs | NG27 | | |
| Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
| Older people with social care needs and multiple long-term conditions | NG22 | | |
| Developing and updating local formularies | MPG1 | | |
| Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset | NG16 | | |
| Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
| Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | NG15 | | |
| Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
| Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
| Excess winter deaths and illness and the health risks associated with cold homes | NG6 | | |
| Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
| Oral health: local authorities and partners | PH55 | | |
| Physical activity: exercise referral schemes | PH54 | | |
| Contraceptive services for under 25s | PH51 | | |
| Needle and syringe programmes | PH52 | | |
| Managing medicines in care homes | SC1 | | |
| Domestic violence and abuse: multi-agency working | PH50 | | |
| Behaviour change: individual approaches | PH49 | | |
| Physical activity: brief advice for adults in primary care | PH44 | | |
| Antisocial personality disorder: prevention and management | CG77 | | |
| Hepatitis B and C testing: people at risk of infection | PH43 | | |
| Physical activity: walking and cycling | PH41 | | |
| Social and emotional wellbeing: early years | PH40 | | |
| Healthcare-associated infections: prevention and control | PH36 | | |
| Type 2 diabetes prevention: population and community-level interventions | PH35 | | |
| Unintentional injuries: prevention strategies for under 15s | PH29 | | |
| Unintentional injuries in the home: interventions for under 15s | PH30 | | |
| Unintentional injuries on the road: interventions for under 15s | PH31 | | |
| Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
| Cardiovascular disease prevention | PH25 | | |
| Alcohol-use disorders: prevention | PH24 | | |
| Improving outcomes for people with skin tumours including melanoma | CSG8 | | |
| Rehabilitation after critical illness in adults | CG83 | | |
| Borderline personality disorder: recognition and management | CG78 | | |
| Physical activity for children and young people | PH17 | | |
| Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
| Cardiovascular disease: identifying and supporting people most at risk of dying early | PH15 | | |
| Physical activity in the workplace | PH13 | | |
| Behaviour change: general approaches | PH6 | | |
| Drug misuse in over 16s: psychosocial interventions | CG51 | | |
| Drug misuse in over 16s: opioid detoxification | CG52 | | |
| Improving outcomes for people with brain and other central nervous system tumours | CSG10 | | |
| Improving outcomes for people with sarcoma | CSG9 | | |
| Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
| Improving outcomes in children and young people with cancer | CSG7 | | |
| Improving outcomes in head and neck cancers | CSG6 | | |